Diclofenac inhibits proliferation but not NGF-induced differentiation of PC12 cells

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 3, 2009, Pages 259-262

  Rajabalian, Saeed ^a   Meimandi, Manzumeh Shamsi ^b   Badinloo, Marziyeh ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytotoxicity; Diclofenac; Differentiation; NGF; PC12

Indexed keywords

DICLOFENAC; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; GROWTH INHIBITION; NEURITE; NONHUMAN; PHEOCHROMOCYTOMA; RAT; ANIMAL; CELL STRAIN; CHICK EMBRYO;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHICK EMBRYO; DICLOFENAC; NERVE GROWTH FACTOR; PC12 CELLS; RATS;

EID: 68549125422     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Berenguer B, Sanchez LM, Quilez A, Lopez-Barreiro M, Haro O, Galvez J and Martin MJ (2006). Protective and antioxidant effects of Rhizophora mangle L. against NSAID-induced gastric ulcers. J. Ethnopharmacol., 103: 194-200. (Pubitemid 41796917)
2. Brewer GJ, Torricelli JR, Evege EK and Price PJ (1993). Optimized survival of hippocampal neurons in B27- supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res., 35: 567-576.
3. Brogden RN, Heel RC, Pakes GE, Speight TM and Avery GS (1980). Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic disease and pain of varying origin. Drugs, 20: 24-48. (Pubitemid 11245967)
4. Cantoni L, Valaperta R, Ponsoda X, Castell JV, Baralli D, Rizzardini M, Mangolini A, Hauri L and Villa P (2003). Induction of hepatic heme oxigenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity. J. Hepatol., 38: 776-783. (Pubitemid 36613344)
5. Giovannetti M, Machado MA, Borrelli Junior M, Ikejiri CI, Alonso N and Branco PD (1993). Tissue necrosis: A side effect of sodium diclofenac: Report of cases and discussion of the physiopathology. Rev. Hosp. Clin. Fac. Med. Sao Paulo, 48: 39-42.
6. Gomez-Lechon MJ, Ponsoda X, O'Connor E, Donato T, Castell JV and Jover R (2003a). Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem. Pharmacol., 66: 2155-2167. (Pubitemid 37383730)
7. Gomez-Lechon MJ, Ponsoda X, O'Connor E, Donato T, Jover R and Castell JV (2003b). Diclofenac induced apoptosis in hepatocytes. Toxicol. In Vitro, 17: 675-680.
8. Hickey EJ, Raje RR, Reid VE, Gross SM and Ray SD (2001). Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic and fragmentation and apoptotic cell death. Free Radic. Biol. Med., 31: 139-152.
9. Inoue A, Muranaka S, Fujita H, Kanno T, Tamai H and Utsumi K (2004). Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, AKT, BID, Cytochrome c, and caspase pathway. Free Radic. Biol. Med., 37: 1290-1299. (Pubitemid 39302541)
10. Isom GE and Borowitz JL (1993). PC-12 cells. In: Tyson CA and Frazier JM Editors. Methods in Toxicology, Vol.1A, Academic Press, New York, pp.82-93.
11. Jick SS, Kaye JA and Jick H (2007). Diclofenac and acute myocardial infarction in patients with no major risk factors. Br. J. Clin. Pharmacol., 64: 662-667. (Pubitemid 47568814)
12. Kudo C, Kori M, Matsuzaki K, Yamai K, Nakajima A, Shibuya A, Niwa H, Kamisaki Y and Wada K (2003). Diclofenac inhibits proliferation and differentiation of neural stem cells. Biochem. Pharmacol., 66: 289-295. (Pubitemid 36776402)
13. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD and Smith WL (1994). Differential inhibition of human prostaglandin endoperoxide synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther., 271: 927-934. (Pubitemid 24377783)
14. Pillans PI and O'Connor N (1995). Tissue necrosis and necrotizing fasciitis after intramuscular administration of diclofenac. Ann. Pharmacother., 29: 264-266.
15. Roehm NW, Rodgers GH, Hatfield SM and Glasebrook AL (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods, 142: 257-265.
16. Rygnestad T and Kvam AM (1995). Streptococcal myositis and tissue necrosis with intramuscular administration of diclofenac (voltaren). Acta. Anaesthesiol. Scand., 39: 1128-1130.
17. Sallmann AR (1986). The history of diclofenac. Am. J. Med., 80: 29-33.